Decheng Capital Management Iii (Cayman), LLC Pacific Biosciences Of California, Inc. Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
A detailed history of Decheng Capital Management Iii (Cayman), LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Decheng Capital Management Iii (Cayman), LLC holds 1,463,872 shares of PACB stock, worth $2.56 Million. This represents 6.76% of its overall portfolio holdings.
Number of Shares
1,463,872
Previous 1,463,872
-0.0%
Holding current value
$2.56 Million
Previous $19.5 Million
37.22%
% of portfolio
6.76%
Previous 10.32%
Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
258Shares Held
234MCall Options Held
1.02MPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$58.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$45.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$41.3 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$40.9 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$29.3 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $393M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...